Pertussis: microbiology, disease, treatment, and prevention

PE Kilgore, AM Salim, MJ Zervos… - Clinical microbiology …, 2016 - Am Soc Microbiol
Pertussis is a severe respiratory infection caused by Bordetella pertussis, and in 2008,
pertussis was associated with an estimated 16 million cases and 195,000 deaths globally …

Deaths following vaccination: What does the evidence show?

ER Miller, PL Moro, M Cano, TT Shimabukuro - Vaccine, 2015 - Elsevier
Vaccines are rigorously tested and monitored and are among the safest medical products
we use. Millions of vaccinations are given to children and adults in the United States each …

[HTML][HTML] Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices …

JL Liang - MMWR. Recommendations and reports, 2018 - cdc.gov
This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older …

Centers for Disease Control and … - MMWR: Morbidity & …, 2012 - search.ebscohost.com
Abstract Since 2005, the Advisory Committee on Immunization Practices (ACIP) has
recommended a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) …

Prenatal Tdap immunization and risk of maternal and newborn adverse events

JB Layton, AM Butler, D Li, KA Boggess, DJ Weber… - Vaccine, 2017 - Elsevier
Many countries recommend combined tetanus toxoid, reduced diphtheria toxoid and
acellular pertussis immunization (Tdap) during pregnancy to stimulate transplacental …

[HTML][HTML] Combined reduced-antigen content tetanus, diphtheria, and acellular pertussis (tdap) vaccine-related erythema nodosum: case report and review of vaccine …

PR Cohen - Dermatology and Therapy, 2013 - Springer
Background Vaccination programs reduce the morbidity and mortality of diphtheria,
pertussis, and tetanus. Erythema nodosum is a reactive erythema that can be associated …

Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®) A Review of its Properties and Use as a Single-Dose Booster …

PL McCormack - Drugs, 2012 - Springer
Reduced-antigen, combined diphtheria, tetanus and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …

Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population

HF Tseng, LS Sy, L Qian, SM Marcy… - Clinical infectious …, 2013 - academic.oup.com
Background. Published data on the safety of tetanus-diphtheria-acellular pertussis vaccine
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …

[PDF][PDF] Vaccination indications and limits in the elderly

TK Triglav, M Poljak - Acta Dermatovenerol Alp Pannonica Adriat, 2013 - acta-apa.org
Infections are a major cause of morbidity and mortality in the elderly. Although vaccination is
crucial for preventing infectious diseases, the ability of the elderly to establish an effective …

Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged≥ 65 years, Vaccine Adverse Event Reporting System …

P Haber, PL Moro, C Ng, GM Dores, S Perez-Vilar… - Vaccine, 2020 - Elsevier
Abstract Introduction The Advisory Committee on Immunization Practices (ACIP)
recommends vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular …